Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Krishnan

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
EMBO Molecular Medicine|October 31, 2022
Diagnostic biomarkers for active tuberculosis: progress and challengesBetânia M F Nogueira, Sonya Krishnan, Beatriz Barreto-Duarte, et al.
European Journal of Immunology|July 11, 2012
The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controlsHiromi Imamichi, Richard A Lempicki, Joseph W Adelsberger, et al.
Frontiers in Immunology|June 25, 2021
Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIVSonya Krishnan, Artur T L Queiroz, Amita Gupta, et al.
Journal of Neurosurgery. Spine|February 4, 2022
Risk factors for surgical intervention in patients with primary spinal infection on initial presentationYike Jin, Ann Liu, Jessica R Overbey, et al.
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
Eclinicalmedicine|June 8, 2023
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trialMariana Araújo-Pereira, Sonya Krishnan, Padmini Salgame, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2025
The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-AnalysisLeonardo Martinez, Jeffrey I Campbell, Lauren Linde, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
EMBO Molecular Medicine|October 31, 2022
Diagnostic biomarkers for active tuberculosis: progress and challengesBetânia M F Nogueira, Sonya Krishnan, Beatriz Barreto-Duarte, et al.
European Journal of Immunology|July 11, 2012
The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controlsHiromi Imamichi, Richard A Lempicki, Joseph W Adelsberger, et al.
Frontiers in Immunology|June 25, 2021
Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIVSonya Krishnan, Artur T L Queiroz, Amita Gupta, et al.
Journal of Neurosurgery. Spine|February 4, 2022
Risk factors for surgical intervention in patients with primary spinal infection on initial presentationYike Jin, Ann Liu, Jessica R Overbey, et al.
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
Eclinicalmedicine|June 8, 2023
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trialMariana Araújo-Pereira, Sonya Krishnan, Padmini Salgame, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2025
The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-AnalysisLeonardo Martinez, Jeffrey I Campbell, Lauren Linde, et al.
Pageof 2